What Researchers Did
Researchers studied how hyperbaric oxygen therapy affected 52 patients experiencing blood loss from stomach and duodenal bleeding.
What They Found
The study found that hyperbaric oxygen therapy, administered at 1.6-2.0 ATA for 40 minutes over 6-10 sessions, helped reduce hypoxia and eliminate the compensatory overactivity of the heart. This decreased the extra workload on the heart, while not significantly affecting the patients' external breathing function.
What This Means for Canadian Patients
For Canadian patients experiencing severe blood loss from stomach or duodenal ulcers, this research suggests HBOT could be a supportive treatment to lessen the strain on their heart. It indicates a potential role for HBOT in stabilizing cardiovascular function during recovery from significant gastrointestinal bleeding.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study's limitations include its small sample size of 52 patients, its age from 1981, and the abstract does not specify if a control group was used for comparison.